Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Earnings, Dividends, Sales Driving Nutrition - Pharma Stocks: Muscle Warfare, GNC, Vitamin Shoppe, Sterotaxis, Organovo



Earnings, Dividends, Sales Driving Nutrition - Pharma Stocks: Muscle Warfare,
                  GNC, Vitamin Shoppe, Sterotaxis, Organovo

PR Newswire

CORAL SPRINGS, Florida, October 24, 2013

CORAL SPRINGS, Florida, October 24, 2013 /PRNewswire/ --

Market news updates and reports for today's active sports nutrition &
pharmaceutical companies:  Muscle Warfare International Inc. (OTC: MWAR), GNC
Holdings, Inc. (NYSE: GNC), Vitamin Shoppe, Inc. (NYSE:VSI), Stereotaxis, Inc.
(NASDAQ: STXS) and Organovo Holdings, Inc. (NYSE: ONVO).

Muscle Warfare International Inc. (OTC: MWAR) CEO discusses 3rd Quarter
Disclosure - Muscle Warfare International is a cutting edge sports nutrition
manufacturer that is passionately driven to create and distribute the absolute
highest quality products in the marketplace. Daniel Amato, President and CEO
of Muscle Warfare stated "I am very excited about the 3rd quarter financials
our revenues have increased over the 2nd quarter numbers by 40 percent, gross
profits are up by 60% and our net loss is down by 24%, the reported numbers
represent consolidated financials for all three of MWAR's companies as well as
MWAR.  Muscle Warfare is in the growth stage of our company and spending money
on advertising, acquiring inventory, attending trade shows and building a
strong and viable sales team. We will continue to search for areas to improve
within MWAR and continue to increase our revenues as well as profits."

Read the full release athttp://www.fnmprofiles.com/profiles-mwar.html

Muscle Warfare has been conducting business since 2002 with annual revenues of
approximately $1,000,000 (one million dollars) plus. The company has been
recognized as a proven winner within the industry with many successes and
proven track record marketing and branding sports nutrition products through
multiple brands and marketing strategies. Some of Muscle Warfare clients
consist of GNC, Inc., Vitamin Shoppe, Europa Sports Products, Fitness First
USA and many others.

The Board of Directors of GNC Holdings, Inc. (NYSE: GNC) (the "Company")
authorized and declared the quarterly cash dividend for the fourth quarter of
2013 of $0.15 per share of the Company's common stock.  The dividend will be
paid on or about December 27, 2013 to stockholders of record as of the close
of business on December 13, 2013.

Vitamin Shoppe, Inc. (NYSE: VSI), a leading multi-channel specialty retailer
of nutritional products, today announced that the Company will release its
fiscal third quarter 2013 financial results before the market open on Tuesday,
November 5, 2013.  A conference call will be webcast the same day beginning at
8:30 a.m. Eastern Time.  Interested investors and other parties may listen to
the webcast of the conference call by logging on to the Investor Relations
section of the Company's website at http://www.vitaminshoppe.com.  A
telephonic replay will be available for one week beginning at 11:30 a.m.
Eastern Time on November 5, 2013.  The replay can be accessed by dialing
1-877-870-5176 or for international callers 1-858-384-5517. The passcode for
the replay is 6370052.  The webcast will also be archived on the Company's
website at http://www.vitaminshoppe.com.

Stereotaxis, Inc. (NASDAQ: STXS) announced that the Ministry of Health, Labor
and Welfare (MHLW) in Japan has classified its Niobe(R) Magnetic Navigation
System as a C2 medical device. The C2 classification recognizes the Niobe
system as a new, distinctive technology with clinical benefits and is the
highest of five reimbursement categories for medical devices in Japan. The
MHLW also approved reimbursement for two electrophysiology (EP) ablation
catheters compatible with Niobe magnetic navigation, effective October 1,
2013.

Organovo Holdings, Inc. (NYSE: ONVO) ("Organovo"), a creator and manufacturer
of functional, three-dimensional human tissues for medical research and
therapeutic applications, today provided a summary of the data presented at
the 3rd Annual Cell Therapy Bioprocessing Conference in Bethesda, MD
International Bioprocessing Conference on October 22, 2013. Building on data
first presented at the Experimental Biology conference in April 2013, the
company presented data demonstrating retention of key liver functions in
bioprinted tissues for up to 40 days, longer than one month.

MusclePharm Corporation (OTCQB: MSLP), a nutritional supplement company
focused on active lifestyles, recently announced that Sydney Rollock has
joined the company as Chief Marketing Officer. In this role, Rollock will
oversee global brand management, global marketing and sales, as well as help
lead MusclePharm's corporate strategy to ultimately grow product lines and
revenue streams..

FinancialNewsMedia.com   is leading provider of third party publishing & news
dissemination services.  If you would like more information regarding our news
coverage solutions, please visit http://www.financialnewsmedia.com   for more
details.  Get an edge on the market with our Premium News Alerts   that are
FREE for a limited time at http://www.financialnewsmedia.com/.  Follow us on
Facebook:  http://www.facebook.com/financialnewsmedia   and
Twitter: http://twitter.com/FNMgroup

DISCLAIMER:  FN Media Group LLC (FNMG) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels.  FNMG is NOT affiliated in any manner
with any company mentioned herein.  FNMG and its affiliated companies are a
news dissemination and financial marketing solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security.  FNMG's market updates,
news alerts and corporate profiles are NOT a solicitation or recommendation to
buy, sell or hold securities.  The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted as research
material.  All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial professional before
considering any level of investing in stocks.  The companies that are
discussed in this release may or may not have approved the statements made in
this release.  FNMG is not liable for any investment decisions by its readers
or subscribers.  Investors are cautioned that they may lose all or a portion
of their investment when investing in stocks. FNMG was compensated one
thousand two hundred fifty dollars for the dissemination of this news release
by Muscle Warfare International Inc. (OTC: MWAR).

FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company:  FN Media Group, LLC
Contact email:  editor@financialnewsmedia.com
U.S. Phone: +1(954)345-0611
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement